Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin in FESS for Chronic Rhinosinusitis With Nasal Polyps
NCT07855315Not yet recruiting
- Sponsor
- Services Institute of Medical Sciences
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Randomised, open-label trial of desmopressin in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Services Institute of Medical Sciences. Primary endpoint: Intraoperative Blood Loss During Functional Endoscopic Sinus Surgery. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
desmopressin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07855315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07855315.